Search - tctmd.com

Displaying 21 - 40 of 307

Sort: Relevancy | Date

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

L.A. McKeown

May 10, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

Presentation ACC 2024

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

Presenter: Young-Guk Ko

April 08, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

Presentation TCT 2023

TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry

Presenter: Kazuki Tobita

October 25, 2023

Presentation TCT 2023

TCT 469: Optical coherence tomography predicts major adverse limb events in patients with femoropopliteal artery disease

Presenter: Donna Lin

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

TCT 157: Sirolimus-Coated Balloon in Femoropopliteal Steno-Occlusive Disease: Efficacy, Safety and One-Year Outcomes. An All-Comers Registry.

Presenter: Marco Ferrone

October 24, 2023

Presentation TCT 2023

Percutaneous Transmural Bypass for Long and Complex Femoropopliteal Lesions: Clinical Outcomes of the DETOUR-2 Study

Presenter: Ajanta De

October 24, 2023

News Daily News

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

Todd Neale

October 16, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News LINC 2023

FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA

L.A. McKeown

June 08, 2023

News Conference News ISET 2023

Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine

Caitlin E. Cox

January 26, 2023

News Conference News ISET 2023

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Caitlin E. Cox

January 20, 2023

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

Presentation TCT 2022

TCT 209: Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Patients With Diabetes Mellitus: Results of the Randomized Chocolate Touch Study

Presenter: Sahil Parikh

September 17, 2022

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

Advertisement

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

What’s Going to Be Hot at ACC 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry

TCT 469: Optical coherence tomography predicts major adverse limb events in patients with femoropopliteal artery disease

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

TCT 157: Sirolimus-Coated Balloon in Femoropopliteal Steno-Occlusive Disease: Efficacy, Safety and One-Year Outcomes. An All-Comers Registry.

Percutaneous Transmural Bypass for Long and Complex Femoropopliteal Lesions: Clinical Outcomes of the DETOUR-2 Study

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA

Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

TCT 209: Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Patients With Diabetes Mellitus: Results of the Randomized Chocolate Touch Study

Worse Complications After PVI in Women Highlight Research Gaps

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content